For traditional approval, CAR T therapies will need to establish superiority over current standard treatments, including ...
The FDA is raising the bar for approval of CAR T-cell therapies in oncology. | The FDA is raising the bar for approval of CAR ...
The move towards a higher threshold for showing efficacy for new CAR-Ts comes after the FDA loosened the requirements for ...
3hon MSN
A subset of patients with depression could benefit from anti-inflammatory treatment, study finds
At any given moment in time, more than 400 million individuals worldwide are battling depression. The antidepressant ...
Adults with type 2 diabetes or overweight or obesity who received GLP-1s do not have increased risk for obesity-related ...
Naoise Mac Giollabhui, PhD, of the Department of Psychiatry at Mass General Brigham, is the lead author of a paper published in American Journal of ...
A new study from researchers at Cambridge, Mass.-based Harvard University found that blockbuster GLP-1 drugs such as Ozempic and Zepbound may have a minimal effect on an individual’s risk of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback